PartsTable TECHNICAL DATA SHEET
NSN 6505-01-057-7410Government record, cited

Lypressin Nasal Solution6505-01-057-7410

NSN 6505-01-057-7410 · NIIN 010577410
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-057-7410 · 6505010577410 · NIIN 010577410 · 01-057-7410 · FSC 6505 Drugs and Biologicals · DIAPID · NDC00078-0042-38
Nearby stock numbers  ·
Features
  • Lypressin Nasal Solution — FSC 6505
  • Administration: NASAL
  • Primary Container Content Quantity: 8.000 MILLILITERS
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Type: BOTTLE, SQUEEZE SPRAY
  • Pharmaceutical Vehicle Type: AQUEOUS
  • Total Primary Container Quantity: 6
Identification
  • NSN: 6505-01-057-7410
  • NIIN: 010577410
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Lypressin Nasal Solution, cataloged under National Stock Number 6505-01-057-7410, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 6 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.

Technical Specifications
ParameterValue
NSN6505-01-057-7410
Item NameLypressin Nasal Solution
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
AdministrationNASAL
Primary Container Content Quantity8.000 MILLILITERS
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container TypeBOTTLE, SQUEEZE SPRAY
Pharmaceutical Vehicle TypeAQUEOUS
Total Primary Container Quantity6
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
DIAPID 3/1 Design control — primary reference
Novartis Pharmaceuticals Corporation
NDC00078-0042-38 3/1 Design control — primary reference
Novartis Pharmaceuticals Corporation

Frequently Asked Questions

What is NSN 6505-01-057-7410?

NSN 6505-01-057-7410 is a Lypressin Nasal Solution, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-057-7410?

Key specifications for 6505-01-057-7410: Administration: NASAL; Primary Container Content Quantity: 8.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE, SQUEEZE SPRAY. 6 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-057-7410 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com